12.2.09 Crocker SLE

download 12.2.09 Crocker SLE

of 24

Transcript of 12.2.09 Crocker SLE

  • 7/26/2019 12.2.09 Crocker SLE

    1/24

    Systemic Lupus

    Erythematosus

    Justin A. CrockerAM Report 12/2/09

  • 7/26/2019 12.2.09 Crocker SLE

    2/24

    SLE

    Autoimmune disease that aects mu!tisystems 1." mi!!ion cases o !upus

    #re$a!ence o 1% to &' per 100(000 popu!ation )omen * Men + 9,1 ratio 90- cases are omen Arican Americans * )hites

    nset usua!!y eteen aes o 1" and &" years(ut

    Can occur in chi!dhood or !ater in !ie

  • 7/26/2019 12.2.09 Crocker SLE

    3/24

    C!inica! Maniestations

    or the purpose o identiyin patients inc!inica! studies( a person has SLE i & or

    more o the 11 criteria are present( seria!!yor simu!taneous!y( durin any inter$a! ooser$ation. 3speciicity 9"-( sensiti$ity%"-4

    5t is important to rememer that a patientmay ha$e SLE and not ha$e & criteria.

  • 7/26/2019 12.2.09 Crocker SLE

    4/24

    Criteria

    1. 6utter!y rash

    2. 7iscoid !upus

    8. #hotosensiti$ity

    &. ra! u!cers

    ". Arthritis

    . Serositis

    %. :euro!oic d/o

    '. ;emato!oic d/o

    9. Rena! d/o

    10.5mmuno!oic, anti+

    7:A( anti+Sm( a!se

    pos S

  • 7/26/2019 12.2.09 Crocker SLE

    5/24

    Cutaneous

    Most common rash is photosensiti$e( raisederythematous ma!ar rash. ""+'"- de$e!op atsome point in disease

    7iscoid Lupus Erythematosus 37LE4, 1"+80-circu!ar( sca!y hyperpimented !esions itherythematous rim( atrophic center=can edisiurin

    Mouth/$aina!/nasa! u!cers A!opecia, may e diuse or patchy. ccurs "0-

  • 7/26/2019 12.2.09 Crocker SLE

    6/24

    Ma!ar Rash

  • 7/26/2019 12.2.09 Crocker SLE

    7/24

    7iscoid Rash

  • 7/26/2019 12.2.09 Crocker SLE

    8/24

    ra! >!cers

  • 7/26/2019 12.2.09 Crocker SLE

    9/24

    MS?

    #o!yarthritis( mi!d to disa!in( occurs mostre@uent!y in hands( rists( knees. ccurs 90-

    Joint deormities occur in on!y 10- Arthritis o SLE tends to e transitory 5 sin!e oint has persistent pain( consider

    osteonecrosis 3pre$a!ence increased in SLE o$erenera! popu!ation( especia!!y i on steroids.4

    Myositis ith e!e$ated C? and eakness rare!yoccurs

  • 7/26/2019 12.2.09 Crocker SLE

    10/24

    Arthritis

  • 7/26/2019 12.2.09 Crocker SLE

    11/24

    Serositis + #u!monary

    #!euritis ith or ithout eusion

    + i case is mi!d( tB, :SA57S

    + i case is se$ere( tB, steroids Lie+threatenin maniestations, interstitia!

    in!ammation hich can !ead to irosis and

    intra+a!$eo!ar hemorrhae. A!so pneumothoraB and pu!monary ;

  • 7/26/2019 12.2.09 Crocker SLE

    12/24

    Serositis Cardiac

    #ericarditis, most common cardiac maniestation

    and usua!!y responds to :SA57s.

    Myocarditis 3rare4 and irinous endocarditis3Liman+Sacks4 may occur. Steroids p!us

    treatment or C;/arrhythmia or emo!ic e$ents.

    M5 due to atherosc!erosis can occur in D8" y/o

  • 7/26/2019 12.2.09 Crocker SLE

    13/24

    :euro

    Crania! or periphera! neuropathy occurs in 10+1"-( it isproa!y secondary to $ascu!itis in sma!! arteriessupp!yin ner$es.

    7iuse C:S dysunction, memory and reasonindiicu!ty ;eadache, i eBcruciatin( oten indicate acute !are Seiures o any type #sychosis, must distinuish rom steroid+induced

    psychosis 3occurs in 1steeks o tB at doses F&0mprednisone and reso!$es ater se$era! days o reducinor stoppin tB4

  • 7/26/2019 12.2.09 Crocker SLE

    14/24

    Cont.

  • 7/26/2019 12.2.09 Crocker SLE

    15/24

    ;eme

    Anemia, usua!!y :ormochromic(

    normocytic

    Leukopenia, a!most a!ays consists o!ymphopenia( not ranu!ocytopenia

  • 7/26/2019 12.2.09 Crocker SLE

    16/24

    Rena!

    :ephritis, usua!!y asymptomatic( so

    a!ays check >A i patient has knon or

    suspected SLE ccurs ear!y in course o disease+i not

    present /in 1 yr( proa!y i!! not occur.

    ;isto!oic c!assiication y rena! iopsy isuseu! to p!an therapy

  • 7/26/2019 12.2.09 Crocker SLE

    17/24

    ;isto!oic C!assiications C!ass 5 is minima! mesania! !omeru!onephritis hich is

    histo!oica!!y norma! on !iht microscopy ut ith mesania!deposits on e!ectron microscopy.

    C!ass 55 is ased on a indin o mesania! pro!ierati$e !upusnephritis.

  • 7/26/2019 12.2.09 Crocker SLE

    18/24

    5mmuno!ou!ins

    Anti+ds7:A 5H, $ery speciic( may

    corre!ate ith disease acti$ity

    Anti+Sm, speciic( ut on!y present in 2"-o cases( does not corre!ate ith acti$ity

    A#LA, not speciic. >sed to identiy

    patients at increased risk or c!ots(thromocytopenia and eta! !oss

  • 7/26/2019 12.2.09 Crocker SLE

    19/24

    A:A

    A:A, positi$e in 9"- o cases. #retest

    proai!ity aects interpretation. 5n #C# settin(

    2- or SLE. 5n rheum, 80- Lo #ositi$e 31,10 or !oer4, SLE !ike!ihood

    D2- 3D2- or rheumato!oists4

    ;ih #ositi$e 31,820 or hiher4, SLE !ike!ihood,

    2+1%- 382+'1- or rheumato!oists4

    SLE speciic patterns, Rim and ;omoenous

  • 7/26/2019 12.2.09 Crocker SLE

    20/24

    Additiona! ork+up

    + Serum cr. and a!umin

    + C6C / di

    + >/A

    + ESR

    +

    Comp!ement !e$e!s+ Rena! B i arranted

  • 7/26/2019 12.2.09 Crocker SLE

    21/24

  • 7/26/2019 12.2.09 Crocker SLE

    22/24

    Conser$ati$e manaement

    or those /out maor oran in$o!$ement. :SA57s, to contro! pain( se!!in( and e$er

    Caution / :SA57S thouh. SLE pts are atincreased risk or aseptic meninitis

    Antima!aria!s, Henera!!y to treat atiue ointpain( skin rashes( and in!ammation o the !uns

    Common!y used, ;ydroBycho!or@uine >sed a!one or in comination ith other drus

  • 7/26/2019 12.2.09 Crocker SLE

    23/24

    Cont.

    Corticosteroids 3Mainstay o SLE treatment4

    sua!!y start ith hih+dose 5G pu!se and con$ertto # steroids ith oa! o taperin and

    con$ertin to somethin e!se.

    Common!y used, prednisone( hydrocortisone(methy!predniso!one( and deBamethasone

  • 7/26/2019 12.2.09 Crocker SLE

    24/24

    5mmunosuppressi$es

    #rimari!y or C:S/rena! in$o!$ement Mycopheno!ate moeti! 3ce!!cept4 Aathioprine 3imuran4, re@uires se$era! months to e

    eecti$e( eecti$e in sma!!er percentae o patients M